The Global Alliance for TB Drug Development
Acronym: TB Alliance
General Information
Identification Code: 636752920377-18
Website: [object Object]
Entity Form: 501(c)(3)
Registration Category: Non-governmental organisations, platforms and networks and similar
Registration Date: 1/20/2016
Last Update: 3/12/2024
EP Accredited Number: 0
Mission & Interests
Goals: TB Alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.
Interests Represented: Does not represent commercial interests
Interests:
- Budget
- Public health
- Research and innovation
Levels of Interest:
- global
Activities
Main EU Legislative Proposals: EU legislative proposal: European Health Emergency Preparedness and Response Authority (HERA) – meetings with European Commission officials; Horizon Europe, European and Developing Countries Clinical Trials Partnership (EDCTP), and EU initiatives connected to research and innovation (R&I) – meetings with European Commission officials; EU Global Health Strategy – meetings with European Commission officials; EU Pharmaceutical Package – contribution to consultation and meetings with European Commission officials
Communication Activities: We participated in regular meetings with HERA, EDCTP3 and European Commission officials regarding TB Alliance Research and Innovation activities, and actively engaged in communications related to ongoing Commission policies related to EDCTP3 initiatives, EU Global Health Strategy, the EU Pharmaceutical Package and the possibility for the introduction of a novel Priority Review Voucher (PRV) type mechanism to encourage R&I investments in neglected disease research. Furthermore, we highlighted the contributions of the Commission and its various initiatives to support the work of global medical R&I in the context of the "Keeping the Promise: Product Development Partnerships' Role in the New Age of Health Research and Product Development" Report that we help draft and distribute.
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 80 Pine Street20th floor
Post Code: 10005
City: New York
Country: UNITED STATES
Phone: [object Object]
EU Office
Address: 80 Pine Street20th floor
Post Code: 10005
City: New York
Country: UNITED STATES
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Complementary Information: TB Alliance is part of a consortium - UNITE4TB being funded under IMI/IHI AMR Accelerator mechanism.
Membership Information
Members10 Percent: 3
Members25 Percent: 2
Members50 Percent: 0
Members75 Percent: 0
Members: 5
Members F T E: 0.800000011920929
Info Members: Number of persons includes 2 staff/employees and 3 consultants.
Structure
Structure Type: Structure
Is Member Of: - https://era4tb.org/about-imi/
- https://eu-pearl.eu/
- https://www.unite4tb.org/
Organisation Members: DSW - https://www.dsw.org/en/eu/
AMR Stakeholder Network - https://epha.org/amr-stakeholder-network/